pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 3
evorpacept
Adenocarcinoma Of The Gastroesophageal Junction
Leukocyte surface antigen CD47
$ALXOALX ONCOLOGY HOLDINGS INC
0 catalysts
Preclinical
exRP-250
Psoriasis
exRNA Therapeutics Ltd
0 catalysts
Phase 3
exagamglogene autotemcel
Casgevy (exagamglogene autotemcel)
Beta Thalassaemia
B-cell lymphoma/leukemia 11A
Vertex, Inc.
← prev
page 178 of 231
next →
131
Pain89
Neurology1
$VERX
0 catalysts
Phase 2
exaluren
exaluren [INN]
Alport Syndrome
$ELOXEloxx Pharmaceuticals, Inc.
0 catalysts
Phase 1
exarafenib
exarafenib [INN]
Melanoma
Laboratoires Pierre Fabre SA
0 catalysts
Phase 1
exenatide
Byetta (exenatide)
Type 2 Diabetes
$ORMPORAMED PHARMACEUTICALS INC.
0 catalysts
Phase 2
exendin-(9-39)
Hyperinsulinemia
Glucagon-like peptide 1 receptor
Children's Hospital of Philadelphia
0 catalysts
Phase 2
exeporfinium chloride
exeporfinium chloride [INN]
Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infec…
AMR Bio Ltd
0 catalysts
Phase 2
ezeprogind
ezeprogind [INN]
Progressive Supranuclear Palsy
AlzProtect SAS
0 catalysts
Marketed
ezetimibe
Ezetimibe (ezetimibe)
Heterozygous Familial Hypercholesterolemia (heFH)
OEP Pharma
0 catalysts
Phase 2
ezurpimtrostat
ezurpimtrostat [INN]
Bile Duct Cancer (Cholangiocarcinoma)
Genfit SA
0 catalysts
Marketed
factor IX complex
Profilnine SD (factor IX complex)
Hemophilia B (Factor IX Deficiency)
Grifols Biologicals Inc (Inactive)
0 catalysts
Marketed
factor XIII (human)
Corifact (factor XIII (human))
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency)
CSL Behring LLC
0 catalysts
Phase 1
faldoritinib
Refractory Acute Myeloid Leukemia
$BMEABiomea Fusion, Inc.
0 catalysts
Marketed
famciclovir
Famciclovir (famciclovir)
Genital Herpes
Camber Pharmaceuticals Inc
0 catalysts
Marketed
famotidine
Pepcid (famotidine)
Acid Indigestion (Heartburn/Pyrosis)
$KVUEKenvue Inc.
0 catalysts
Phase 2
famzeretcel
famzeretcel [INN]
Retinitis Pigmentosa (Retinitis)
jCyte Inc
0 catalysts
Phase 1
farabursen sodium
Polycystic Kidney Disease
$NVSNOVARTIS AG
0 catalysts
Phase 1
faridoxorubicin
faridoxorubicin [INN]
Dedifferentiated Liposarcoma
Avacta Life Sciences Ltd
0 catalysts
Phase 2
farletuzumab ecteribulin
Triple-Negative Breast Cancer (TNBC)
Eisai Co Ltd
0 catalysts
Phase 3
fasedienol
Aloradine (fasedienol)
Social Anxiety Disorder (SAD/Social Phobia)
$VTGNVistagen Therapeutics, Inc.
0 catalysts
Phase 2
fasudil
BRAVYL (fasudil [INN])
Amyotrophic Lateral Sclerosis
Woolsey Pharmaceuticals Inc
0 catalysts
Phase 3
fazirsiran sodium
Alpha-1 Antitrypsin Deficiency (A1AD)
$ARWRARROWHEAD PHARMACEUTICALS, INC.
0 catalysts
Phase 1
fb-PMT
Recurrent Glioblastoma Multiforme (GBM)
NanoPharmaceuticals LLC
0 catalysts
Marketed
fecal microbiota, live-brpk
Vowst
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Nestle HealthCare Nutrition Inc
0 catalysts
Marketed
fecal microbiota, live-jslm
Rebyota
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Ferring Pharmaceuticals Inc
0 catalysts
Marketed
felbamate
Felbamate Wallace (felbamate)
Generalized Seizures
Wallace Pharmaceuticals Inc
0 catalysts
Marketed
felodipine ER
Felodipine (felodipine)
Hypertension
Method Pharmaceuticals LLC
0 catalysts
Phase 3
felzartamab
felzartamab [INN]
Membranous Glomerulonephritis
$BIIBBIOGEN INC.
0 catalysts
Phase 3
fenebrutinib
Primary Progressive Multiple Sclerosis (PPMS)
Tyrosine-protein kinase BTK
Genentech Inc
0 catalysts